Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Ga... - 04 October 2022 17:00

OKAYAMA, Japan, Oct. 4, 2022 /Kyodo JBN-AsiaNet/ -- Hayashibara Co., Ltd., a member of Nagase Group and headquartered in Okayama City, western Japan, hosted the 24th Trehalose Symposium, with the support of the Japanese Society of Applied Glycoscience, on September 8, 2022. Photo: https://kyodon...

  Climate Change And Health Inequity A Deadly Mix For The Most V... - 29 September 2022 08:01

GENEVA, Sept. 29, 2022 /PRNewswire-AsiaNet/ On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, saying millions more lives are now at risk from cardiovascular disease, which is still the world's biggest killer. Climate ...

  ABILITY DIABETES GLOBAL – A Landmark RCT in the field of PCI f... - 28 September 2022 22:47

TAMPA, Fla., Sept. 28, 2022 /PRNewswire- AsiaNet/- ABILITY DIABETES-GLOBAL [https://www.conceptmedical.com/clinical-program/ability-diabetes-global/](ADG), is the World's largest Randomized Controlled Trial (RCT) for patients with DM (Diabetes Mellitus), comparing head-to-head the Sirolimus el...

  Pharming Announces US FDA Acceptance for Priority Review of it... - 28 September 2022 16:00

LEIDEN, The Netherlands, Sep 28, 2022, /PRNewswire-AsiaNet/-- The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency Pharming Group N.V. ("Pharming" ...

  TargEDys and Inoliva announce they have entered a distribution... - 27 September 2022 19:15

LONGJUMEAU, France, Sept. 27, 2022, /PRNewswire-AsiaNet/-- TargEDys and Inoliva, an affiliate of Abdi Ibrahim, have signed an exclusive marketing and distribution agreement to bring Satylia, a food supplement based on the next-generation probiotic Hafnia alvei HA4597, to the Turkish market. Satylia...

  AAHRPP Accredits Five More Research Organizations, Including F... - 24 September 2022 04:00

WASHINGTON, Sept. 24, 2022 /PRNewswire-AsiaNet/ -- The Association for the Accreditation ( https://c212.net/c/link/?t=0&l=en&o=3657696-1&h=2135994626&u=https%3A%2F%2Fwww.aahrpp.org%2F&a=Accreditation ) of Human Research Protection Programs has accredited five more research organizations, including...

  Ivory Dentin Graft(TM), the First and Only Dentin Graft, Recei... - 21 September 2022 20:29

KEFAR SAVA, Israel, Sept. 21, 2022 /PRNewswire- AsiaNet/- - Ivory Dentin Graft creates a new dentin category of graft substitutes for repair and augmentation of bone defects. Developed by Ivory Graft Ltd.[]https://ivorygraft.com/, the Ivory Dentin Graft(TM) is a new dentin graft. This graft materi...

  The 6th China Health and Senior Care Conference held in southw... - 21 September 2022 16:57

CHONGQING, China, Sept. 21, 2022 /Xinhua-AsiaNet/-- On August 30th, the 6th China Health and Senior Care Conference was held in Huangshui Town, a summer resort in Shizhu Tujia Autonomous County, southwest China's Chongqing Municipality. Hosted by the Revolutionary Committee of the Chinese Kuomi...

  Mediaseek's Proprietary Neurofeedback Engine "Alpha Switch" an... - 21 September 2022 16:00

TOKYO, Sept. 21, 2022 /Kyodo JBN-AsiaNet/ -- - Engine and App Used in Research Paper on Chronic Low Back Pain Treatment at Pain Center of Chiba University Hospital Published in "Scientific Reports" - Mediaseek, Inc. (hereinafter referred to as "Mediaseek") based in Tokyo is pleased to ann...

  Smith+Nephew launches OR3O(TM) Dual Mobility System in Japan f... - 20 September 2022 09:00

LONDON, Sept. 20, 2022 /PRNewswire-AsiaNet/ -- -- Features proprietary OXINIUM(TM) DH material; eliminates Cobalt Chrome alloy reducing wear and corrosion risks [1] Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its OR3O Dual Mobil...